The treatment of locally advanced pancreatic cancer: RESULTS (Part 6)

In: Pancreatic cancer

21 Jul 2012

In this poorly powered study, there were no statistically significant differences in survival or local control among the arms. Median disease-free survival was also similar among treatment groups: 3.7 months with neutron irradiation, 3.4 months with mixed radiation beams and 3.7 months with pure photon irradiation. However, three neutron-irradiated patients suffered moderate to life-threatening gastrointestinal toxicity compared with one patient treated with photons.

Adverse effects of chemoradiotherapy: Chemoradiotherapy can be associated with cytopenia, nausea, vomiting and diarrhea (Table 2). However, these adverse effects are generally tolerable, and treatment-related deaths are unusual. Combination 5-FU and radiation is also well tolerated. Although not superior to 5-FU in efficacy, other chemotherapeutic regimens appear to be more toxic.

TABLE 2 Adverse effects of treatment

Reference Treatment Arm Nausea or vomiting (%) Adverse effects – all grades Diarrhea (%) Leucopenia (%) Thrombocytopenia (%) Treatment-related deaths
A) Chemoradiotherapy versus radiotherapy alone
Moertel et al, RTCT (5-FU) 76 13 100 52 NR
1969 RT alone 40 6 31 7 NR
GITSG 9273, RTCT (60 Gy + 5-FU) 86 7 78 37 NR*
1981 RTCT (40 Gy + 5-FU) 77 6 62 45 1
RT alone (60 Gy) 64 0 52 8 NR*
B) Chemoradiotherapy versus chemotherapy alone
1985 CT (5-FU) NR NR 2P<0.05 NR NR
GITSG 9283, RTCT (5-FU+SMF) 78 46 100 100 NR
1988 CT (SMF) 95 48 100 100 NR
C) Chemoradiotherapy with comparison of different chemotherapy regimens
SWOG, RTCT (mCCNU+5-FU) Did not report adverse effects separated by treatment arm (%)
1980 RTCT (mCCNU+5-FU) CT (testalactone).
GITSG 9277, RTCT (5-FU) 36 0
1985 RTCT (doxorubicin) 53P<0.05 1
Earle et al, RTCT (5-FU) 90 0 50 NR 0
1994 RTCT (hycanthone) 90 2Grade 3+ 0<2000 mm3 NR 1
D) Comparison of different types of radiation beams
RTOG, Photons 9 0 0 NR
1989 Mixed 9 0 0 NR
Neutrons 6Grade 3+ 6Grade 3+ 0(all adverse hematological effects) NR

 *Two other patient deaths noted in report, treatment arm unspecified. 5-FU Bolus 5-fluorouracil; CT Chemotherapy; ECOG Eastern Cooperative Oncology Group; GITSG Gastrointestinal Tumor Study Group; Gy Gray; mCCNU Methyl lomustine; NR Not reported; RT Radiotherapy; RTCT Chemoradiotherapy; RTOG Radiation Therapy Oncology Group; SMF Streptozocin, mitomycin, 5-FU; SWOG Southwest Oncology Group




About this blog

Blog invites submissions of review articles, reports on clinical techniques, case reports, conference summaries, and articles of opinion pertinent to the control of pain and anxiety in dentistry.